378 related articles for article (PubMed ID: 18286246)
21. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies in scleroderma.
Pollard KM; Reimer G; Tan EM
Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161
[TBL] [Abstract][Full Text] [Related]
23. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
[TBL] [Abstract][Full Text] [Related]
24. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
[TBL] [Abstract][Full Text] [Related]
25. RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.
Terras S; Hartenstein H; Höxtermann S; Gambichler T; Kreuter A
Int J Dermatol; 2016 Aug; 55(8):882-5. PubMed ID: 26499848
[TBL] [Abstract][Full Text] [Related]
26. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.
Cepeda EJ; Reveille JD
Curr Opin Rheumatol; 2004 Nov; 16(6):723-32. PubMed ID: 15577611
[TBL] [Abstract][Full Text] [Related]
27. Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?
Benyamine A; Bertin D; Heim X; Granel B; Bardin N
Eur J Intern Med; 2017 Oct; 44():e42-e44. PubMed ID: 28781194
[No Abstract] [Full Text] [Related]
28. Joint contractures responsive to immunosuppressive therapy in a girl with childhood-onset systemic sclerosis double-seropositive for rare anti-nucleolar autoantibodies: a case report.
Tanaka R; Tani Y; Kaburaki Y; Kinoshita M; Kawaguchi Y; Okazaki Y; Kuwana M; Harigai M; Nagata S; Miyamae T
Pediatr Rheumatol Online J; 2021 Mar; 19(1):37. PubMed ID: 33743728
[TBL] [Abstract][Full Text] [Related]
29. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies.
Koenig M; Dieudé M; Senécal JL
Autoimmun Rev; 2008 Sep; 7(8):588-93. PubMed ID: 18617021
[TBL] [Abstract][Full Text] [Related]
31. Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease.
Blann AD; Constans J; Carpentier P; Renard M; Satger B; Guérin V; Boisseau MR; Neau-Cransac N; Conri C
Thromb Res; 2003 Feb; 109(4):203-6. PubMed ID: 12757775
[No Abstract] [Full Text] [Related]
32. Autoantibodies in systemic sclerosis.
Vázquez-Abad D; Rothfield NF
Int Rev Immunol; 1995; 12(2-4):145-57. PubMed ID: 7650418
[TBL] [Abstract][Full Text] [Related]
33. Antinuclear antibody profile in UCD line 200 chickens: a model for progressive systemic sclerosis.
Gruschwitz MS; Shoenfeld Y; Krupp M; Gershwin ME; Penner E; Brezinschek HP; Wick G
Int Arch Allergy Immunol; 1993; 100(4):307-13. PubMed ID: 8386962
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies in systemic sclerosis.
Steen VD
Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
[TBL] [Abstract][Full Text] [Related]
35. Marker antibodies in scleroderma and polymyositis: clinical associations.
de Rooij DJ; Van de Putte LB; Habets WJ; Van Venrooij WJ
Clin Rheumatol; 1989 Jun; 8(2):231-7. PubMed ID: 2547546
[TBL] [Abstract][Full Text] [Related]
36. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
Steen VD; Lucas M; Fertig N; Medsger TA
J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
[TBL] [Abstract][Full Text] [Related]
38. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
Johanet C; Agostini MM; Vayssairat M; Abuaf N
Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
[TBL] [Abstract][Full Text] [Related]
39. [Scleroderma associated autoantibodies - clinical and diagnostic relevance].
Mierau R; Genth E
Z Rheumatol; 2006 Jul; 65(4):279-84. PubMed ID: 16788839
[TBL] [Abstract][Full Text] [Related]
40. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
